The Valley Desk

NCT04607148 · Interventional trial

A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Overall registry status Terminated

Phase 2

Conditions Geographic Atrophy, Macular Degeneration, Age-Related

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov